PAR paradigm biopharmaceuticals limited..

An IL-8 Investigation, page-5

  1. 4,908 Posts.
    lightbulb Created with Sketch. 7636
    Hi Hamman,


    No is the short answer.

    Certainly another inflammatory condition that iPPS could potentially address.

    Inflammatory Bowel Disease (IBD) is the overarching condition under which diseases such as Chron's disease falls. There is definitely some real chance that iPPS can address Chron's disease which I've come across in the past thus by extrapolation, IBD being another inflammatory condition also should be a possible future indication for us.





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
0.000(0.00%)
Mkt cap ! $170.8M
Open High Low Value Volume
43.0¢ 43.0¢ 41.5¢ $141.6K 337.6K

Buyers (Bids)

No. Vol. Price($)
1 9738 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 76716 4
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.